Entropy Technologies LP Buys 15,496 Shares of Amdocs Limited $DOX

Entropy Technologies LP boosted its stake in Amdocs Limited (NASDAQ:DOX) by 59.0% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 41,757 shares of the technology company’s stock after purchasing an additional 15,496 shares during the quarter. Entropy Technologies LP’s holdings in Amdocs were worth $2,725,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the company. TABR Capital Management LLC acquired a new position in shares of Amdocs in the 4th quarter valued at approximately $2,398,000. BNP Paribas Financial Markets raised its position in Amdocs by 85.4% during the fourth quarter. BNP Paribas Financial Markets now owns 201,982 shares of the technology company’s stock valued at $16,262,000 after purchasing an additional 93,036 shares in the last quarter. Aberdeen Group plc raised its position in Amdocs by 13.2% during the fourth quarter. Aberdeen Group plc now owns 263,287 shares of the technology company’s stock valued at $21,197,000 after purchasing an additional 30,723 shares in the last quarter. Arbejdsmarkedets Tillaegspension lifted its stake in Amdocs by 17.5% during the first quarter. Arbejdsmarkedets Tillaegspension now owns 354,383 shares of the technology company’s stock worth $23,127,000 after purchasing an additional 52,906 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC lifted its stake in Amdocs by 1.8% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 3,165,988 shares of the technology company’s stock worth $253,786,000 after purchasing an additional 54,676 shares during the last quarter. Institutional investors own 92.02% of the company’s stock.

Amdocs Price Performance

Shares of DOX opened at $52.10 on Monday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.98 and a current ratio of 0.98. Amdocs Limited has a 52 week low of $49.74 and a 52 week high of $90.29. The stock has a market capitalization of $5.62 billion, a price-to-earnings ratio of 10.42, a PEG ratio of 0.91 and a beta of 0.41. The stock has a fifty day moving average of $55.64 and a 200-day moving average of $65.08.

Amdocs (NASDAQ:DOX) last issued its quarterly earnings data on Thursday, May 14th. The technology company reported $1.78 earnings per share for the quarter, topping analysts’ consensus estimates of $1.77 by $0.01. Amdocs had a return on equity of 19.77% and a net margin of 11.81%.The business had revenue of $1.17 billion for the quarter, compared to analyst estimates of $1.17 billion. During the same quarter in the previous year, the company posted $1.78 EPS. Amdocs’s quarterly revenue was up 3.9% compared to the same quarter last year. As a group, sell-side analysts anticipate that Amdocs Limited will post 6.56 earnings per share for the current fiscal year.

Amdocs Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th will be issued a dividend of $0.569 per share. This represents a $2.28 annualized dividend and a dividend yield of 4.4%. The ex-dividend date is Tuesday, June 30th. Amdocs’s payout ratio is 45.60%.

Analysts Set New Price Targets

DOX has been the subject of several recent analyst reports. KeyCorp assumed coverage on Amdocs in a research report on Monday, June 29th. They set a “sector weight” rating for the company. Wall Street Zen cut Amdocs from a “buy” rating to a “hold” rating in a research report on Sunday, July 5th. Cfra cut Amdocs to a “sell” rating in a research report on Thursday, May 14th. Stifel Nicolaus lowered their target price on Amdocs from $88.00 to $71.00 and set a “buy” rating for the company in a research note on Thursday, May 14th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Amdocs in a report on Friday, May 8th. Three equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $86.67.

About Amdocs

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.